AU2001286403A1 - High affinity integrin polypeptides and uses thereof - Google Patents

High affinity integrin polypeptides and uses thereof

Info

Publication number
AU2001286403A1
AU2001286403A1 AU2001286403A AU8640301A AU2001286403A1 AU 2001286403 A1 AU2001286403 A1 AU 2001286403A1 AU 2001286403 A AU2001286403 A AU 2001286403A AU 8640301 A AU8640301 A AU 8640301A AU 2001286403 A1 AU2001286403 A1 AU 2001286403A1
Authority
AU
Australia
Prior art keywords
polypeptide
amino acid
subunit
cdl
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286403A
Other languages
English (en)
Inventor
M. Amin Arnaout
Rui Li
Jian-Ping Xiong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/758,493 external-priority patent/US7064180B2/en
Priority claimed from US09/805,354 external-priority patent/US7153944B2/en
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU2001286403A1 publication Critical patent/AU2001286403A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001286403A 2000-07-31 2001-07-31 High affinity integrin polypeptides and uses thereof Abandoned AU2001286403A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22195000P 2000-07-31 2000-07-31
US60221950 2000-07-31
US09/758,493 US7064180B2 (en) 2000-07-31 2001-01-11 High affinity integrin polypeptides and uses thereof
US09758493 2001-01-11
US09805354 2001-03-13
US09/805,354 US7153944B2 (en) 2000-07-31 2001-03-13 High affinity integrin polypeptides and uses thereof
PCT/US2001/023957 WO2002009737A1 (en) 2000-07-31 2001-07-31 High affinity integrin polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
AU2001286403A1 true AU2001286403A1 (en) 2002-02-13

Family

ID=56290175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286403A Abandoned AU2001286403A1 (en) 2000-07-31 2001-07-31 High affinity integrin polypeptides and uses thereof

Country Status (5)

Country Link
EP (1) EP1311282A4 (ja)
JP (1) JP2004504827A (ja)
AU (1) AU2001286403A1 (ja)
CA (1) CA2418120A1 (ja)
MX (1) MXPA03000981A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2844287A4 (en) 2012-05-02 2016-01-27 Univ New York METHOD FOR THE TREATMENT AND PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND RELATED DISEASES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4192000A (en) * 1999-04-02 2000-10-23 Abbott Laboratories Lfa-1 regulatory binding site and uses thereof
NZ515238A (en) * 1999-04-02 2005-02-25 Icos Corp Inhibitors of LFA-1 binding to ICAMs and uses thereof
AU2001282880A1 (en) * 2000-07-07 2002-01-21 California Institute Of Technology Proteins with integrin-like activity
US7153944B2 (en) * 2000-07-31 2006-12-26 The General Hospital Corporation High affinity integrin polypeptides and uses thereof
WO2002031511A2 (en) * 2000-10-12 2002-04-18 Icos Corporation Modulation of ligand binding/enzymatic activity of alpha beta proteins

Also Published As

Publication number Publication date
EP1311282A1 (en) 2003-05-21
JP2004504827A (ja) 2004-02-19
CA2418120A1 (en) 2002-02-07
MXPA03000981A (es) 2003-09-05
EP1311282A4 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
US7998738B2 (en) Integrin-binding antibodies
US7179467B2 (en) DCMP2 polypeptide
US7723483B2 (en) Method for enhancing or inhibiting insulin-like growth factor-I
US7153944B2 (en) High affinity integrin polypeptides and uses thereof
EA032728B1 (ru) Антитела для выявления комплексов интегрина в ffpe материале
US9868787B2 (en) Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I
AU775300B2 (en) Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
US7064180B2 (en) High affinity integrin polypeptides and uses thereof
AU2001286403A1 (en) High affinity integrin polypeptides and uses thereof
Violette et al. Differences in the binding of blocking anti-CD11b monoclonal antibodies to the A-domain of CD11b.
US20090221094A1 (en) Anthrax Polypeptide Binding
US20040005550A1 (en) Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3
WO2000032633A1 (en) Novel adhesion molecule and methods of use
AU675073B2 (en) Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
US5877275A (en) Controlling cellular immune/inflammatory responses with β2 integrins
Welzenbach Differential effects of low molecular weight inhibitors on the conformation and the immunologic function of the adhesion receptor LFA-1
Leisner et al. Bidirectional Transmembrane Modulation of Integrin

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application